Revvity (RVTY) Shares Outstanding (2009 - 2026)
Revvity's (RVTY) quarterly Shares Outstanding (Entity) came in at $111.6 million in Q3 2026, down 4.08% on a YoY basis from $116.3 million in Q3 2025, and little changed quarter-over-quarter from $111.6 million in Q2 2026.
Analysis
Revvity (RVTY) Shares Outstanding (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Shares Outstanding (Entity) for 18 consecutive years, with $111.6 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Shares Outstanding (Entity) fell 4.08% year-over-year to $111.6 million; the trailing twelve-month figure through Jul 2026 stood at $111.6 million (down 4.08% YoY), and the FY2025 full-year result was $112.3 million, down 6.93% from the prior year.
- Shares Outstanding (Entity) was little changed at $111.6 million in Q3 2026 per RVTY's latest filing, from $111.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $126.3 million in Q1 2023 and bottomed at $111.6 million in Q3 2026.
- Historically, Shares Outstanding (Entity) has averaged $121.2 million across 5 years, with a median of $123.4 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) grew 12.67% in 2022, then decreased 6.93% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $126.2 million in 2022, then slipped by 2.21% to $123.4 million in 2023, then dropped by 2.25% to $120.6 million in 2024, then retreated by 6.93% to $112.3 million in 2025, then fell by 0.62% to $111.6 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $111.6 million, $111.6 million, and $112.3 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 371.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 705.30 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 282.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 151.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 111.58 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 155.96 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 26.75 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 56.42 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 129.98 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 152.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 111.58 Mn |
| Apr 5, 2026 | 111.85 Mn |
| Dec 28, 2025 | 116.54 Mn |
| Sep 28, 2025 | 115.41 Mn |
| Jun 29, 2025 | 117.51 Mn |
| Mar 30, 2025 | 120.14 Mn |
| Dec 29, 2024 | 122.76 Mn |
| Sep 29, 2024 | 122.81 Mn |
| Jun 30, 2024 | 123.35 Mn |
| Mar 31, 2024 | 123.43 Mn |
| Dec 31, 2023 | 124.70 Mn |
| Oct 1, 2023 | 123.99 Mn |
| Jul 2, 2023 | 125.22 Mn |
| Apr 2, 2023 | 126.29 Mn |
| Jan 1, 2023 | 126.16 Mn |
| Oct 2, 2022 | 126.16 Mn |
| Jul 3, 2022 | 126.13 Mn |
| Apr 3, 2022 | 126.14 Mn |
| Jan 2, 2022 | 116.17 Mn |
| Oct 3, 2021 | 114.51 Mn |